Compare EW & AFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EW | AFL |
|---|---|---|
| Founded | 1958 | 1955 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Accident &Health Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 50.2B | 59.5B |
| IPO Year | 1999 | 1994 |
| Metric | EW | AFL |
|---|---|---|
| Price | $86.24 | $113.49 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 21 | 11 |
| Target Price | $96.37 | ★ $110.18 |
| AVG Volume (30 Days) | ★ 4.4M | 2.0M |
| Earning Date | 04-23-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 2.10% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.66 | ★ 1.98 |
| Revenue | $6,067,600,000.00 | ★ $17,164,000,000.00 |
| Revenue This Year | $13.39 | N/A |
| Revenue Next Year | $9.81 | $1.69 |
| P/E Ratio | $130.13 | ★ $56.93 |
| Revenue Growth | ★ 11.55 | N/A |
| 52 Week Low | $72.30 | $96.95 |
| 52 Week High | $88.28 | $119.81 |
| Indicator | EW | AFL |
|---|---|---|
| Relative Strength Index (RSI) | 61.14 | 44.21 |
| Support Level | $81.39 | $108.82 |
| Resistance Level | $86.95 | $116.45 |
| Average True Range (ATR) | 2.40 | 2.08 |
| MACD | 0.52 | -0.52 |
| Stochastic Oscillator | 82.70 | 20.51 |
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
Aflac Inc offers supplemental health insurance and life insurance in the United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accident, dental and vision, disability, and long-term-care insurance. It markets its products through independent distributors, selling the majority of its policies directly to consumers at their places of work, and also reaches out to its customers outside of their worksite through digital mediums. The company has two reportable business segments: Aflac Japan, which generates the maximum revenue, and Aflac U.S.